Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition)Haowen Tang, Chaoliu Dai, Xinyu Bi et al.|BioScience Trends|2024Cited by 20
Clinical practice status of the adjuvant therapy in hepatocellular carcinoma (HCC): A survey of Chinese hepatobiliary surgeons.Hui‐Chuan Sun, Haiqing Wang, Jia Fan et al.|Journal of Clinical Oncology|2022Cited by 1